Takafumi Okada
- Microbiology top 2%
- Bacterial Infections and Vaccines 4
- Microbial infections and disease research 3
- Epidemiology top 10%
- Pneumonia and Respiratory Infections 11
- Respiratory viral infections research 9
- Influenza Virus Research Studies 2
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Immunodeficiency and Autoimmune Disorders 2
-
- Cardiac Ischemia and Reperfusion 2
Takafumi Okada
20 papers receiving 442 citations
Peers
Comparison fields: 5 of 59
- Microbiology 224
- Epidemiology 380
- Molecular Medicine 13
- Hepatology 20
- Pharmacology 41
Countries citing papers authored by Takafumi Okada
This map shows the geographic impact of Takafumi Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takafumi Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takafumi Okada more than expected).
Fields of papers citing papers by Takafumi Okada
This network shows the impact of papers produced by Takafumi Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takafumi Okada. The network helps show where Takafumi Okada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takafumi Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2017 | 15 | |
| 3 | 2017 | 1 | |
| 4 | 2017 | 2 | |
| 5 | 2012 | 16 | |
| 6 | 2012 | 161 | |
| 7 | 2012 | 30 | |
| 8 | 2011 | 5 | |
| 9 | 2010 | 22 | |
| 10 | 2010 | 0 | |
| 11 | 2010 | 6 | |
| 12 | 2009 | 96 | |
| 13 | 2009 | 7 | |
| 14 | 2008 | 14 | |
| 15 | 2006 | 20 | |
| 16 | 2000 | 3 | |
| 17 | 1996 | 28 | |
| 18 | [A clinical evaluation of azithromycin in the treatment of pediatric infection]. | 1996 | 1 |
| 19 | [Two cases of the brachiocephalic artery avulsion due to blunt chest trauma]. | 1992 | 1 |
| 20 | Fluorescent antibody technic in diagnosis of canine distemper. | 1969 | 3 |
About Takafumi Okada
Takafumi Okada is a scholar working on Microbiology, Epidemiology and Emergency Medicine, having authored 23 papers that have together received 459 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (11 papers), Respiratory viral infections research (9 papers), Bacterial Infections and Vaccines (4 papers), Microbial infections and disease research (3 papers), Influenza Virus Research Studies (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). The work is most often cited by research in Microbiology (224 citations), Epidemiology (380 citations) and Molecular Medicine (13 citations). Takafumi Okada has collaborated with scholars based in Japan and United States. Frequent co-authors include Kimiko Ubukata, Miyuki Morozumi, Satoshi Iwata, Naoko Chiba, Hiroshi Sakata, Takeshi Tajima, Maki Hasegawa, Keita Matsubara, Osamu Komiyama and Keisuke Sunakawa. Their work appears in journals such as Clinical Infectious Diseases, Emerging infectious diseases and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.